AVIRAtea Pharmaceuticals, Inc.
$5.15+73% 1Y
$5.15
$2.9652 weeks$6.15
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +6% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AVIR is trading
Atea Pharmaceuticals, Inc. is +73% over the past year while the S&P 500 is +18%: 55 points ahead of the market.
+73%
1-year return · S&P 500 +18%
- vs 200-day average
- +6.0%
vs 200-day average · close to trend
- RSI (14)
- 43
RSI (14) · neutral
- Below its 52-week high
- 16%
Below its 52-week high
Details›
- Last close2026-10-08
- $5.15
- 1 monthS&P 500 +1.6%
- −2.1%
- 1 yearS&P 500 +18%
- +73%
- 5 yearsS&P 500 +86%
- −85%
- vs 50-day average$5.24
- −1.8%
- 52-week high
- $6.15
- 52-week low
- $2.96
- Annualised volatility
- 47%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $25K
| Year | Return |
|---|---|
| 2026 (year to date) | +44% |
| 2025 | +6.6% |
| 2024 | +9.8% |
| 2023 | −37% |
| 2022 | −46% |
| 2021 | −79% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 3 of 6 | +16% |
| Feb | 6 | 3 of 6 | −3.1% |
| Mar | 6 | 2 of 6 | −0.36% |
| Apr | 6 | 1 of 6 | −15% |
| May | 6 | 3 of 6 | +3.9% |
| Jun | 6 | 2 of 6 | +0.00% |
| Jul | 6 | 5 of 6 | +6.9% |
| Aug | 6 | 3 of 6 | +2.6% |
| Sep | 6 | 1 of 6 | −7.8% |
| Oct | 6 | 3 of 6 | −7.5% |
| Nov | 6 | 2 of 6 | −8.3% |
| Dec | 6 | 5 of 6 | +8.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.